ALFA Finder| Revenue growth | 11% YoY consolidated growth. |
|---|---|
| Margins | Consolidated EBITDA margin at 36.5%, lower YoY. |
| Demand visibility | Strong for HALS series. |
| Management confidence | High, citing highest-ever consolidated sales history. |
Growth
Consolidated revenue grew 11% YoY and 8% QoQ; PAT grew 5% YoY and 26% QoQ.
Outlook
Invested INR 100 Cr in CFCL; Performance Chemical 2 commercialization expected by Q3 FY27.
Risks
EBITDA margins compressed YoY from 41.6% to 36.5% due to higher raw material and operating expenses.
Last quarter's promises, checked
Delivered
- Guided HALS scale-up → 1,000+ tonnes in Q4 (= BEAT)
- Guided subsidiary EBITDA positive → INR 7 Cr in Q4 (= BEAT)
- Guided final dividend → INR 4 per share (= BEAT)
Partly delivered
- Guided Performance Chemical 2 by Sep '26 → Current call says Q3 FY27 (= PARTIAL)
Missed
- Guided 12-month revenue growth → 12% YoY decline (= MISS)
Investor Presentation filed with BSE, NSE: CLEAN. Summary written with AI assistance from the document.
Clean Science & Technology Ltd: key numbers
- Share price
- ₹705.70
- Market cap
- ₹7,500 Cr
- Revenue (annual)
- ₹956.5 Cr
- Net profit (annual)
- ₹229.7 Cr
- P/E (TTM)
- 32.2×Sector 35.5×
- Promoter holding
- 51.29%+0.00% QoQ
- FII holding
- 13.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clean Science & Technology Ltd
All →Clean Science & Technology Earnings Call Transcript: Key Takeaways
Record consolidated quarter, with HALS revenue doubling YoY. Standalone margins compressed as raw-material inflation could not be passed on to customers.
Clean Science & Technology Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹299 Cr (+22% YoY), PAT ₹56 Cr (+0.5%), EBITDA margin 31.2% (vs 36.4%). HALS-led growth; margins hit by geopolitical headwinds.
Clean Science & Technology Q2 FY27 Results: Net Profit ₹55.7 Cr, Up 0.5% YoY
Clean Science & Technology Ltd reported revenue from operations of ₹299.4 Cr (+22.4% YoY) and net profit of ₹55.7 Cr (+0.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹55.7 Cr · +0.5% YoY
Clean Science & Technology Business Update
Clean Science's subsidiary Clean Fino-Chem completed product trials for advanced HALS grades developed with Geneus Chem AG. Commercial launch of the new range is expected in H2 FY2026-27.
Clean Science & Technology Other Announcement
Clean Science and Technology Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Clean Science & Technology Board Meeting Date
Clean Science and Technology Ltd has scheduled a board meeting for October 31, 2026, to approve unaudited financial results for the quarter and half year ending September 2026.